Skip navigation
Log in for access to resources and a secure project workspace. Register LOGIN
Library header image


Publications Referencing Tufts CTSI

  1. Aouad MT, Nasr VG, Yazbeck-Karam VG, Bitar MA, Bou Khalil M, Beyrouthy O, Harfouche D, Terrin N, Siddik-Sayyid S. A comparison between dexamethasone and methylprednisolone for vomiting prophylaxis after tonsillectomy in inpatient children: a randomized trial. Anesth Analg. 2012 Oct;115(4):913-20.
  2. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. Osteoarthritis Cartilage. 2011 Jun;19(6):611-9.
  3. Barton Laws M, Bradshaw YS, Safren SA, Beach MC, Lee Y, Rogers W, Wilson IB. Discussion of sexual risk behavior in HIV care is infrequent and appears ineffectual: A mixed methods study. AIDS Behav. 2011 May;15(4):812-22.
  4. Boyd CM, Kent DM. Evidence-based medicine and the hard problem of multimorbidity. Journal of General Internal Medicine. 2014 Apr;29(4):552-3.
  5. Broce JC, Price LL, Liangos O, Uhlig K, Jaber BL. Hospital-acquired acute kidney injury: an analysis of nadir-to-peak serum creatinine increments stratified by baseline estimated GFR. Clin J Am Soc Nephrol. 2011 Jul;6(7):1556-65.
  6. Brugge D, Lane KJ, Stewart A, Tai A, Woodin M. Highway proximity associations with blood markers of inflammation: evidence for a role for IL-1ýý. Journal of Toxicology and Environmental Health. Part A. 2013;76(3):201-5.
  7. Byington CL, Higgins S, Kaskel FJ, Purucker M, Davis JM, Smoyer WE. The CTSA mentored career development program: supporting the careers of child health investigators. Clin Trans Sci. 2014 Feb;7(1):44-7.
  8. Cai X, Razmara A, Paulus JK, Switkowski K, Fariborz PJ, Goryachev SD, D'Avolio L, Feldmann E, Thaler DE. Case Misclassification in Studies of Spinal Manipulation and Arterial Dissection. Journal of Stroke and Cerebrovascular Diseases: the Official Journal of the National Stroke Association. 2014 Jul 29.
  9. Capario LC, Kent CM, Strauss GM. Effects of chemotherapy on survival of elderly patients with small-cell lung cancer: analysis of the SEER-medicare database. Journal of Thoracic Oncology. 2013 Oct; 8(10):1272-81.
  10. Carini LM, Nephew BC. Effects of early life social stress on endocrinology, maternal behavior, and lactation in rats. Hormones and Behavior. 2013 Sep;64(4):634-41.
  11. Carroll TL, Fedore LW, Aldahlawi MM. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope. 2012 Nov;122(11):2473-81.
  12. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, Wallace B, Hersh CP, Bagade S, Bertram L, Silverman EK, Trikalinos TA. The COPD genetic association compendium: A comprehensive online database of COPD genetic associations. Hum Mol Genet. 2010 Feb 1;19(3):526-34.
  13. Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, Lomas DA, Anderson W, Beaty TH, Hokanson JE, Crapo JD, Laird N, Silverman EK; COPDGene and Eclipse Investigators. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol. 2011 Dec;45(6):1147-53.
  14. Castaldi PJ, Dahabreh IJ, Ioannidis JP. An empirical assessment of validation practices for molecular classifiers. Brief Bioinform. 2011 May;12(3):189-202.
  15. Castaldi PJ, Demeo DL, Hersh CP, Lomas DA, Soerheim IC, Gulsvik A, Bakke P, Rennard S, Pare P, Vestbo J; AATGM Investigators; ICGN Investigators, Silverman EK. Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax. 2011 Oct;66(10):903-9.
  16. Castaldi PJ, DeMeo DL, Kent DM, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Stocks JM, Stoller JK, Strange C, Turino G, Sandhaus RA, Griffith JL, Silverman EK. Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency. Am J Epidemiol. 2009 Oct 15;170(8):1005-13.
  17. Castaldi PJ, Rogers WH, Safran DG, Wilson IB. Inhaler costs and medication nonadherence among seniors with chronic pulmonary disease. Chest. 2010 Sep;138(3):614-20.
  18. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012 May 24;119(21):4845-50.
  19. Ceglia L, Chiu GR, Harris SS, Araujo AB. Serum 25-hydroxyvitamin D concentration and physical function in adult men. Clin Endocrinol (Oxf). 2011 Mar;74(3):370-6.
  20. Ceglia L, da Silva Morais M, Park LK, Morris E, Harris SS, Bischoff-Ferrari HA, Fielding RA, Dawson-Hughes B. Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol. 2010 Apr;41(2-3):137-42.
  21. Ceglia L, Niramitmahapanya S, da Silva Morais M, Rivas DA, Harris SS, Bischoff-Ferrari H, Fielding RA, Dawson-Hughes B. A randomized study on the effect of vitamin D supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. Journal of Clinical Endocrinology & Metabolism. 2013 Dec;98(12):E1927-35.
  22. Ceglia L, Rivas DA, Pojednic RM, Price LL, Harris SS, Smith D, Fielding RA, Dawson-Hughes B. Effects of alkali supplementation and vitamin D insufficiency on rat skeletal muscle. Endocrine. 2013 Oct;44(2):454-64.
  23. Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F, Masoumi A, Hogan MC, Winklhofer FT, Braun W, Thompson PA, Meyers CM, Kelleher C, Schrier RW. The HALT polycystic kidney disease trials: Design and implementation. Clin J Am Soc Nephrol. 2010 Jan;5(1):102-9.
  24. Chung M, Balk EM, Ip S, Lee J, Terasawa T, Raman G, Trikalinos T, Lichtenstein AH, Lau J. Systematic review to support the development of nutrient reference intake values: challenges and solutions. American Journal of Clinical Nutrition. 2010 Aug;92(2):273-6.
  25. Coglin DT, Leyenaar JK, Shen M, Bergert L, Engel R, Hershey D, Mallory L, Rassbach C, Woehrlen T, Cooperberg D. Pediatric discharge content: a multisite assessment of physician preferences and experiences. Hospital Pediatrics. 2014 Jan;4(1):9-15.
  26. Concannon TW, Kent DM, Normand SL, Newhouse JP, Griffith JL, Cohen J, Beshansky JR, Wong JB, Aversano T, Selker HP. Comparative effectiveness of ST-segment-elevation myocardial infarction regionalization strategies. Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):506-13.
  27. Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, Conway PH, Daudelin D, Morrato EH, Leslie LK. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med. 2012 Aug;27(8):985-91.
  28. Concannon TW, Nelson J, Goetz J, Griffith JL. A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):14-20.
  29. Concannon TW, Nelson J, Kent DM, Griffith JL. Evidence of systematic duplication by new percutaneous coronary intervention programs. Circulation. Cardiovascular Quality and Outcomes. 2013 Jul;6(4):400-8.
  30. Correll CU, Leslie LK, Rodday AM, Saunders TS, Parsons SK, Robb AS, Zima BT. Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics. J Child Adolesc Psychopharmacol. 2014 Mar;24(2):90.
  31. Corlin L, Woodin M, Newhide D, Brown E, Valentina Diaz S, Chi A, Brugge D. Asthma Associations in Children Attending a Museum of Science. Int. J. Environ. Res. Public Health. 2013; 10: 4117-4131.
  32. Critchfield AS, Paulus JK, Farez R, Urato AC. Abnormal analyte preeclampsia: do the second-trimester maternal serum analytes help differentiate preeclampsia subtypes? Journal of Perinatology. 2013 Oct;33(10):754-8.
  33. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA. 2011 Feb 23;305(8):822-3.
  34. Dahabreh IJ, Kent DM. Towards an epidemiology of the known unknowns in cryptogenic stroke. Heart. 2012 Aug;98(15):1114-6.
  35. Dahabreh IJ, Kitsios GD, Kent DM, Trikalinos TA. Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis. Genet Med. 2010 Oct;12(10):606-15.
  36. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: Systematic review and meta-analysis. JAMA. 2011 Mar 23;305(12):1225-33.
  37. Dahabreh IJ, Schmid CH, Lau J, Varvarigou V, Murray S, Trikalinos TA. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. American Journal of Epidemiology. 2013 Jun;177(12):1317-25.
  38. Dahabreh IJ, Sheldrick RC, Paulus JK, Chung M, Varvarigou V, Jafri H, Rassen JA, Trikalinos TA, Kitsios GD. Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. Eur Heart J. 2012 Aug;33(15):1893-901
  39. Dahabreh IJ, Trikalinos TA, Paulus JK. Parity and risk of lung cancer in women: systematic review and meta-analysis of epidemiological studies. Lung Cancer. 2012 May;76(2):150-8.
  40. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr. 2011 Apr;65(4):501-7.
  41. Davis CC, Claudius M, Palinkas LA, Wong JB, Leslie LK. Putting families in the center: family perspectives on decision making and ADHD and implications for ADHD care. J Atten Disord. 2012 Nov;16(8):675-84.
  42. Deo A, Schmid CH, Earley A, Lau J, Uhlig K. Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis. 2011 Sep;58(3):349-55.
  43. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilarino-Guell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ, Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Independent and joint effects of the MAPT and SNCA genes in parkinson disease. Ann Neurol. 2011 May;69(5):778-92.
  44. Elkind MS, Kent DM, Ruthazer R, Thaler DE, Di Angelantonio E, Homma S, Di Tullio MR, Mas JL, Mattle HP, Nedeltchev K, Papetti F, Serena J, Weimar C, Reisman M, Lutz JS, Wessler BS, Meier B. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014 Jan;7(1):125.
  45. Freeman LM, Rush JE, Meurs KM, Bulmer BJ, Cunningham SM. Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy. J Feline Med Surg. 2013 Feb;15(2):74-80.
  46. Gabbay E, Calvo-Broce J, Meyer KB, Trikalinos TA, Cohen J, Kent DM. The empirical basis for determinations of medical futility. J Gen Intern Med. 2010 Oct;25(10):1083-9.
  47. Gaither SE, Chen EE, Corriveau KH, Harris PL, Ambady N, Sommers SR. Monoracial and Biracial Children: Effects of Racial Identity Saliency on Social Learning and Social Preferences. Child Development. 2014 Jul.
  48. Galvan A, Ioannidis JP, Dragani TA. Beyond genome-wide association studies: Genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010 Mar;26(3):132-41.
  49. Garwick-Coppens SE, Herman A, Harper SQ. Construction of permanently inducible miRNA-based expression vectors using site-specific recombinases. BMC Biotechnol. 2011 Nov 16;11:107.
  50. Goff SL, Kleppel R, Lindenauer PK, Rothberg MB. Hospital workers' perceptions of waste: a qualitative study involving photo-elicitation. BMJ Quality & Safety. 2013 Oct;22(10):826-35.
  51. Goff SL, Knee A, Morello M, Grow D, Bsat F. Handoff quality for obstetrical inpatients varies depending on time of day and provider type. Journal of Reproductive Medicine. 2014 Mar-Apr;59(3-4):95-102.
  52. Goff SL, Pekow PS, Avrunin J, Lagu T, Markenson G, Lindenauer PK. Patterns of obstetric infection rates in a large sample of US hospitals. American Journal of Obstetrics & Gynecology. 2013 Jun;208(6):456.e1-13.
  53. Greenblatt DJ, Peters DE, Oleson LE, Harmatz JS, MacNab MW, Berkowitz N, Zinny MA, Court MH. Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase. Br J Clin Pharmacol. 2009 Dec;68(6):920-7.
  54. Hacker K, Tendulkar SA, Rideout C, Bhuiya N, Trinh-Shevrin C, Savage CP, Grullon M, Strelnick H, Leung C, DiGirolamo A. Community capacity building and sustainability: outcomes of community-based participatory research. Prog Community Health Partnersh. 2012 Fall;6(3):349-60.
  55. Heffernan KS, Kuvin JT, Sarnak MJ, Perrone RD, Miskulin DC, Rudym D, Chandra P, Karas RH, Menon V. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2011 Aug;26(8):2515-21.
  56. Heffernan KS, Wanke C, Dong K, Warner PJ, Anskat PE, Karas RH, Kuvin JT. Racial differences in central hemodynamic burden in men with HIV: preliminary findings. Ethnicity & Disease. 2013;23(2):217-22.
  57. Hekman JP, Karas AZ, Sharp CR. Psychogenic Stress in Hospitalized Dogs: Cross Species Comparisons, Implications for Health Care, and the Challenges of Evaluation. Animals. 2014 Jun;4(2):331-347.
  58. Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):302-9.
  59. Ioannidis JP, Castaldi P, Evangelou E. A compendium of genome-wide associations for cancer: Critical synopsis and reappraisal. J Natl Cancer Inst. 2010 Jun 16;102(12):846-58.
  60. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet. 2009 May;10(5):318-29.
  61. Jaber BL, Almarzouqi L, Borgi L, Seabra VF, Balk EM, Madias NE. Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia. Am J Med. 2011 Oct;124(10):977.e1-9.
  62. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; Human Genome Epidemiology Network. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Hum Genet. 2011 Aug;19(8):833-6.
  63. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. Ann Intern Med. 2011 Mar 15;154(6):421-5.
  64. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. BMJ. 2011 Mar 16;342:d631.
  65. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic risk prediction studies: The GRIPS statement. Circ Cardiovasc Genet. 2011 Apr;4(2):206-9.
  66. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest. 2011 Sep;41(9):1004-9.
  67. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol. 2011 Apr;26(4):255-9.
  68. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ; GRIPS Group. Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement. Genet Med. 2011 May;13(5):453-6.
  69. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, GRIPS Group. Strengthening the reporting of genetic RIsk prediction studies: The GRIPS statement. PLoS Med. 2011 Mar;8(3):e1000420.
  70. Jarrett OD, Wanke CA, Ruthazer R, Bica I, Isaac R, Knox TA. Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus. AIDS Patient Care and STDs. 2013 May;27(5):266-71.
  71. Johnson TA, Qiu J, Plaut AG, Holyoak T. Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease. J Mol Biol. 2009 Jun 12;389(3):559-74.
  72. Kaitin KI. Deconstructing the drug development process: The new face of innovation. Clin Pharmacol Ther. 2010 Mar;87(3):356-61.
  73. Kaitin KI. The Landscape for Pharmaceutical Innovation: Drivers of Cost-Effective Clinical Research. Pharm Outsourcing. 2010 May;2010.
  74. Kaitin KI, D'Agostino RB, Selker HP, Oye KA, Eichler HG, Stockbridge NL, Mehta CR, McElwee NE, Honig PK, Erban JK. A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials. Clin Pharmacol Ther. 2014 Feb;95(2):147.
  75. Kawut SM, Bagiella E, Lederer DJ, Shimbo D, Horn EM, Roberts KE, Hill NS, Barr RG, Rosenzweig EB, Post W, Tracy RP, Palevsky HI, Hassoun PM, Girgis RE; ASA-STAT Study Group. Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation. 2011 Jun 28;123(25):2985-93.
  76. Kawut SM, Bagiella E, Shimbo D, Lederer DJ, Al-Naamani N, Roberts KE, Barr RG, Post W, Horn EM, Tracy R, Hassoun P, Girgis R, ASA-STAT Study Group. Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemp Clin Trials. 2011 Mar;32(2):280-7.
  77. Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG. Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Pediatric Blood & Cancer. 2014 Feb;61(2):269-75.
  78. Kelly MJ, Pennarola BW, Rodday AM, Parsons SK. Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatric Blood & Cancer. 2012 Oct;59(4):725-31.
  79. Kelly MJ, Trikalinos TA, Dahabreh IJ, Gianferante M, Parsons SK. Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: A systematic review and meta-analysis. American Journal of Hematology. 2014 Jun.
  80. Kent DM, Boyd CM. Evidence-based medicine and the hard problem of multimorbidity. J Gen Intern Med. 2014 Apr;29(4):552.
  81. Kent DM, Kitsios G. Against pragmatism: On efficacy, effectiveness and the real world. Trials. 2009 Jul 6;10:48.
  82. Kent DM, Kitsios GD. Percutaneous closure of patent foramen ovale: a near-perfect treatment ruined by careful study? Circ Cardiovasc Qual Outcomes. 2012 May;5(3):414-5.
  83. Kent DM, Kitsios GD, Thaler DE. Response to letter regarding article, "Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials". Stroke. 2013 Dec;44(12):e234. doi: 10.1161/STROKEAHA.113.003654. Epub 2013 Nov 5.
  84. Kent DM, Lindenauer PK. Aggregating and disaggregating patients in clinical trials and their subgroup analyses. Ann Intern Med. 2010 Jul 6;153(1):51-2.
  85. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.
  86. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, DiTullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013 Aug;81(7):619-25.
  87. Kent DM, Shah ND. Personalizing evidence-based primary prevention with aspirin: individualized risks and patient preference. Circ Cardiovasc Qual Outcomes. 2011 May;4(3):260-2.
  88. Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009 Nov 25;302(20):2254-6.
  89. Kent DM, Trikalinos TA, Hill MD. Are unadjusted analyses of clinical trials inappropriately biased toward the null? Stroke. 2009 Mar;40(3):672-3.
  90. Kent DM, Weiss CO, Varadhan R, Puhan MA, Bandeen-Roche K, Boyd CM, Vickers A. Multimorbidity and evidence generation. J Gen Intern Med. 2014 Apr;29(4):653.
  91. Kerkhof HJ, Lories RJ, Meulenbelt I, Jonsdottir I, Valdes AM, Arp P, Ingvarsson T, Jhamai M, Jonsson H, Stolk L, Thorleifsson G, Zhai G, Zhang F, Zhu Y, van der Breggen R, Carr A, Doherty M, Doherty S, Felson DT, Gonzalez A, Halldorsson BV, Hart DJ, Hauksson VB, Hofman A, Ioannidis JP, Kloppenburg M, Lane NE, Loughlin J, Luyten FP, Nevitt MC, Parimi N, Pols HA, Rivadeneira F, Slagboom EP, Styrkarsdottir U, Tsezou A, van de Putte T, Zmuda J, Spector TD, Stefansson K, Uitterlinden AG, van Meurs JB. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 2010 Feb;62(2):499-510.
  92. Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, Fortier I, Garcia-Closas M, Gwinn M, Higgins JP, Janssens AC, Ostell J, Owen RP, Pagon RA, Rebbeck TR, Rothman N, Bernstein JL, Burton PR, Campbell H, Chockalingam A, Furberg H, Little J, O'Brien TR, Seminara D, Vineis P, Winn DM, Yu W, Ioannidis JP. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009 Aug 1;170(3):269-79.
  93. Kitsios G, Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: A comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet. 2009 Jun 4;10:50.
  94. Kitsios GD, Dahabreh IJ, Abu Dabrh AM, Thaler DE, Kent DM. Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence. Stroke. 2012 Feb;43(2):422-31.
  95. Kitsios GD, Dahabreh IJ, Trikalinos TA, Schmid CH, Huggins GS, Kent DM. Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies. Circ Cardiovasc Genet. 2011 Feb 1;4(1):58-67.
  96. Kitsios GD, Stefanidis I, Zintzaras E. Lack of association between common endothelial nitric oxide synthase gene haplotypes and left ventricular hypertrophy in hypertension. DNA Cell Biol. 2010 Jun;29(6):273-6.
  97. Kitsios GD, Tangri N, Castaldi PJ, Ioannidis JP. Laboratory mouse models for the human genome-wide associations. PLoS One. 2010 Nov 1;5(11):e13782.
  98. Kitsios GD, Thaler DE, Kent DM. Potentially large yet uncertain benefits: a meta-analysis of patent foramen ovale closure trials. Stroke. 2013 Sep;44(9):2640-3.
  99. Kitsios GD, Zintzaras E. Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: The CUMAGAS-HYPERT database. Am J Hypertens. 2010 Mar;23(3):305-13.
  100. Kitsios GD, Zintzaras E. Genome-wide association studies: Hypothesis-"free" or "engaged"? Transl Res. 2009 Oct;154(4):161-4.
  101. Kitsios GD, Zintzaras E. Genomic convergence of genome-wide investigations for complex traits. Ann Hum Genet. 2009 Sep;73(Pt 5):514-9.
  102. Koulouridis I, Alfayez M, Tighiouart H, Madias NE, Kent DM, Paulus JK, Jaber BL. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. American Journal of Kidney Diseases. 2013 Oct;62(4):730-7.
  103. Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis. 2013 Jan;61(1):44-56.
  104. Kraft P, Zeggini E, Ioannidis JP. Replication in genome-wide association studies. Stat Sci. 2009 Nov 1;24(4):561-73.
  105. Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta-analytic approach. J Am Coll Cardiol. 2010 Jul 27;56(5):392-406.
  106. Kroenke K, Kapoor W, Helfand M, Meltzer DO, McDonald MA, Selker H. Training and career development for comparative effectiveness research workforce development: CTSA consortium strategic goal committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci. 2010 Oct;3(5):258-62.
  107. Laws MB, Bradshaw YS, Safren SA, Beach MC, Lee Y, Rogers W, Wilson IB. Discussion of sexual risk behavior in HIV care is infrequent and appears ineffectual: a mixed methods study. AIDS Behav. 2011 May;15(4):812-22.
  108. Lee JY, Luc S, Greenblatt DJ, Kalish R, McAlindon TE. Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important. Lupus. 2013 Apr;22(5):541-2.
  109. Lee JY, Harvey WF, Price LL, Paulus JK, Dawson-Hughes B, McAlindon TE. Relationship of bone mineral density to progression of knee osteoarthritis. Arthritis and Rheumatism. 2013 Jun;65(6):1541-6.
  110. Leslie LK, Cohen JT, Newburger JW, Alexander ME, Wong JB, Sherwin ED, Rodday AM, Parsons SK, Triedman JK. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation. 2012 May 29;125(21):2621-9.
  111. Leslie LK, Rodday AM, Saunders TS, Cohen JT, Wong JB, Parsons SK. Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians. Pediatrics. 2012 Feb;129(2):222-30.
  112. Leung J, Nguyen-Traxler A, Lee EM, Yip JS, Weinstock JV, Chan WW, Ngo P, Weinstein BJ, Bonis PA. Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy and Asthma Proceedings. 2012 Nov;33(6):519-24.
  113. Leyenaar JK, Capra LA, O'Brien ER, Leslie LK, Mackie TI. Determinants of career satisfaction among pediatric hospitalists: a qualitative exploration. Academic Pediatrics. 2014 Jul-Aug;14(4):361-8.
  114. Leyenaar JK, Lagu T, Shieh MS, Pekow PS, Lindenauer PK. Variation in Resource Utilization for the Management of Uncomplicated Community-Acquired Pneumonia across Community and Children's Hospitals. Journal of Pediatrics. 2014 Sep;165(3):585-91.
  115. Leyenaar JK, Shieh MS, Lagu T, Pekow PS, Lindenauer PK. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatric Infectious Disease Journal. 2014 Apr;33(4):387-92.
  116. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP; 23andMe Genetic Epidemiology of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium; Parkinson's Disease GWAS Consortium; Wellcome Trust Case Control Consortium 2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012;8(3):e1002548.
  117. Linder DE, Freeman LM, Sutherland-Smith J. Association between subcutaneous fat thickness measured on thoracic radiographs and body condition score in dogs. American Journal of Veterinary Research. 2013 Nov;74(11):1400-3.
  118. Lubin AS, Snydman DR, Ruthazer R, Bide P, Golan Y. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant staphylococcus aureus bloodstream infections. Clin Infect Dis. 2011 Apr 15;52(8):997-1002.
  119. Maldonado-Arocho FJ, Green C, Fisher ML, Paczosa MK, Mecsas J. Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathogens. 2013;9(6):e1003415.
  120. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis. 2011 Feb;214(2):468-73.
  121. Mann E, Goff SL, Colon-Cartagena W, Bellantonio S, Rothberg MB. Do-not-hospitalize orders for individuals with advanced dementia: healthcare proxies' perspectives. Journal of the American Geriatrics Society. 2013 Sep;61(9):1568-73.
  122. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012 Aug 7;345:e4944.
  123. Marriott LK, Nelson DA, Allen S, Calhoun K, Eldredge CE, Kimminau KS, Lucero RJ, Pineda-Reyes F, Rumala BB, Varanasi AP, Wasser JS, Shannon J. Using health information technology to engage communities in health, education, and research. Sci Transl Med. 2012 Feb 1;4(119):119mr1.
  124. Martinez LS, Rubin CL, Russell B, Leslie LK, Brugge D. Community conceptualizations of health: implications for transdisciplinary team science. Clin Transl Sci. 2011 Jun;4(3):163-7.
  125. Martinez LS, Russell B, Rubin CL, Leslie LK, Brugge D. Clinical and translational research and community engagement: implications for researcher capacity building. Clin Transl Sci. 2012 Aug;5(4):329-32.
  126. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, Lo G, Dawson-Hughes B. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 2013 Jan 9;309(2):155-62.
  127. Mehrotra P, Labib SB, Schick EC. Differential effects of dobutamine versus treadmill exercise on left ventricular volume and wall stress. J Am Soc Echocardiogr. 2012 Aug;25(8):911-8.
  128. Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol. 2011 Jan;6(1):7-13.
  129. Milne CP, Kaitin KI. Impact of the new US health-care-reform legislation on the pharmaceutical industry: Who are the real winners? Clin Pharmacol Ther. 2010 Nov;88(5):589-92.
  130. Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. American Journal of Kidney Diseases. 2014 Feb;63(2):214-26.
  131. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011 Sep;65(9):1005-15.
  132. Mitri J, Nelson J, Ruthazer R, Garganta C, Nathan DM, Hu FB, Dawson-Hughes B, Pittas AG. Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program. European Journal of Clinical Nutrition. 2014 Mar;68(3):376-83.
  133. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. American Journal of Clinical Nutrition. 2011 Aug;94(2):486-94.
  134. Mokhtarani M, Diaz GA, Rhead W, Berry SA, Lichter-Konecki U, Feigenbaum A, Schultze A, Longo N, Bartley J, Berquist W, Gallagher R, Smith W, McCandless SE, Harding C, Rockey DC, Vierling JM, Mantry P, Ghabril M, et al. Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Molecular genetics and metabolism. 2013 Dec;110(4):446-53.
  135. Mokhtarani M, Diaz GA, Rhead W, Lichter-Konecki U, Bartley J, Feigenbaum A, Longo N, Berquist W, Berry SA, Gallagher R, Bartholomew D, Harding CO, Korson MS, McCandless SE, Smith W, Vockley J, Bart S, Kronn D, Zori R, Cederbaum S, Dorrani N, Merritt JL 2nd, Sreenath-Nagamani S, Summar M, Lemons C, Dickinson K, Coakley DF, Moors TL, Lee B, Scharschmidt BF. Urinary phenylacetylglutamine as dosing
    biomarker for patients with urea cycle disorders. Mol Genet Metab. 2012 Nov;107(3):308-14.
  136. Monteleone JP, Mokhtarani M, Diaz GA, Rhead W, Lichter-Konecki U, Berry SA, Lemons C, Dickinson K, Coakley D, Lee B, Scarschmidt BF. Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders. Journal of Clinical Pharmacology. 2013 Jul;53(7):699-710.
  137. Morrato EH, Concannon TW, Meissner P, Shah ND, Turner BJ. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. Journal of Comparative Effectiveness Research. 2013 Mar;2(2):185-94.
  138. Moyer LJ, Carbone ET, Anliker JA, Goff SL. The Massachusetts BMI letter: a qualitative study of responses from parents of obese children. Patient Education and Counseling. 2014 Feb;94(2):210-7.
  139. Muldoon EG, Allison GM, Gallagher D, Snydman DR, Bergin C. Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey. European Journal of Clinical Microbiology & Infectious Diseases. 2013 Nov;32(11):1465-70.
  140. Muldoon EG, Epstein L, Logvinenko T, Murray S, Doron SI, Snydman DR. The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients. Anaerobe. 2013 Dec;24:79-81.
  141. Muldoon EG, Snydman DR, Penland EC, Allison GM. Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. Clinical Infectious Diseases. 2013 Aug;57(3):419-24.
  142. Nasr VG, Schumann R, Bonney I, Diaz L, Ahmed I. Performance validation of a modified magnetic resonance imaging-compatible temperature probe in children. Anesth Analg. 2012 Jun;114(6):1230-4.
  143. Nihashi T, Dahabreh IJ, Terasawa T. Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis. American Journal of Neuroradiology. 2013 May;34(5):944-50.
  144. Nihashi T, Dahabreh IJ, Terasawa T. PET in the clinical management of glioma: evidence map. American Journal of Roentgenology. 2013 Jun;200(6):W654-60.
  145. Okparavero AA, Tighiouart H, Krishnasami Z, Wyatt CM, Graham H, Hellinger J, Inker LA. Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. Aniviral Therapy. 2013;18(6):793-802.
  146. Padmapriyadarsini C, Bhavani PK, Tang A, Kumar H, Ponnuraja C, Narendran G, Hanna E, Ramesh C, Chandrasekar C, Wanke C, Swaminathan S. Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy. International Journal of Infectious Diseases. 2013 Dec;17(12):e1154-9.
  147. Padmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Dyslipidemia among HIV-infected patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in india. Clin Infect Dis. 2011 Feb 15;52(4):540-6.
  148. Parsons SK, Roberts SB, Must A, Zhang FF, Kelly MJ, Saltzman E. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014 Mar;133(3):e704.
  149. Patkar A, Gilmer W, Pae CU, Vöhringer PA, Ziffra M, Pirok E, Mulligan M, Filkowski MM, Whitham EA, Holtzman NS, Thommi SB, Logvinenko T, Loebel A, Masand P, Ghaemi SN. A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One. 2012;7(4):e34757.
  150. Pauker SG. Probability distributions: what's in a shape? Medical Decision Making. 2013 Feb;33(2):133-5.
  151. Pauker SG. Moments when utilities are functional. Medical Decision Making. 2014 Jan;34(1):4-7.
  152. Paulus JK, Santoyo-Vistrain R, Havelick D, Cohen A, Kalyesubula R, Ajayi IO, Mattsson JG, Adami HO, Dalal S. Global teaching and training initiatives for emerging cohort studies. Journal of Epidemiology and Global Health. 2012 Sep;2(3):125-33.
  153. Pelajo CF, Lopez-Benitez JM, Kent DM, Price LL, Miller LC, Dawson-Hughes B. 25-hydroxyvitamin D levels and juvenile idiopathic arthritis: is there an association with disease activity? Rheumatol Int. 2012 Dec;32(12):3923-9.
  154. Pelajo CF, Lopez-Benitez JM, Miller LC. 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol. 2011 Sep;38(9):2000-4.
  155. Pereira TV, Patsopoulos NA, Salanti G, Ioannidis JP. Discovery properties of genome-wide association signals from cumulatively combined data sets. Am J Epidemiol. 2009 Nov 15;170(10):1197-206.
  156. Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT; HALT PKD Study Group, Meyers CM. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2011 Oct;6(10):2508-15.
  157. Pfeiffer T, Bertram L, Ioannidis JP. Quantifying selective reporting and the proteus phenomenon for multiple datasets with similar bias. PLoS One. 2011 Mar 29;6(3):e18362.
  158. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009 Mar;94(3):827-32.
  159. Pittas AG, Nelson J, Mitri J, Hillmann W, Garganta C, Nathan DM, Hu FB, Dawson-Hughes B; Diabetes Prevention Program Research Group. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 2012
  160. Poutsiaka DD, Davidson LE, Kahn KL, Bates DW, Snydman DR, Hibberd PL. Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis. Scandinavian Journal of Infectious Diseases. 2009;41(6-7):469-79.
  161. Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant. 2011 Feb;46(2):300-7.
  162. Purucker M, Smoyer WE, Byington CL, Davis JM, Higgins S, Kaskel FJ. The CTSA mentored career development program: supporting the careers of child health investigators. Clin Transl Sci. 2014 Feb;7(1):44.
  163. Rao M, Mottl AK, Cole SA, Umans JG, Freedman BI, Bowden DW, Langefeld CD, Fox CS, Yang Q, Cupples A, Iyengar SK, Hunt SC, Trikalinos TA. Meta-analysis of genome-wide linkage scans for renal function traits. Nephrol Dial Transplant. 2012 Feb;27(2):647-56.
  164. Rhee MS, Schmid CH, Stevens LA, Forrester JE. Risk factors for proteinuria in HIV-infected and -uninfected hispanic drug users. Am J Kidney Dis. 2008 Oct;52(4):683-90.
  165. Ricciardi R, Nelson J, Griffith JL, Concannon TW. Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection? J Hosp Infect. 2012 Feb;80(2):156-61.
  166. Rodday AM, Parsons SK, Correll CU, Robb AS, Zima BT, Saunders TS, Leslie LK. Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics. Journal of Child and Adolescent Psychopharmacology. 2014 Mar;24(2):90-3.
  167. Rodday AM, Terrin N, Parsons SK. Measuring global health-related quality of life in children undergoing hematopoietic stem cell transplant: a longitudinal study. Health and Quality of Life Outcomes. 2013;11:26.
  168. Rodday AM, Triedman JK, Alexander ME, Cohen JT, Ip S, Newburger JW, Parsons SK, Trikalinos TA, Wong JB, Leslie LK. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic children: a meta-analysis. Pediatrics. 2012 Apr;129(4):e999-1010.
  169. Rubin CL, Martinez LS, Chu J, Hacker K, Brugge D, Pirie A, Allukian N, Rodday AM, Leslie LK. Community-engaged pedagogy: a strengths-based approach to involving diverse stakeholders in research partnerships. Prog Community Health Partnersh. 2012 Winter;6(4):481-90.
  170. Salanti G, Southam L, Altshuler D, Ardlie K, Barroso I, Boehnke M, Cornelis MC, Frayling TM, Grallert H, Grarup N, Groop L, Hansen T, Hattersley AT, Hu FB, Hveem K, Illig T, Kuusisto J, Laakso M, Langenberg C, Lyssenko V, McCarthy MI, Morris A, Morris AD, Palmer CN, Payne F, Platou CG, Scott LJ, Voight BF, Wareham NJ, Zeggini E, Ioannidis JP. Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol. 2009 Sep 1;170(5):537-45.
  171. Segal JB, Kapoor W, Carey T, Mitchell PH, Murray MD, Saag KG, Schumock G, Jonas D, Steinman M, Filart R, Weinberger M, Selker H. Preliminary competencies for comparative effectiveness research. Clin Transl Sci. 2012 Dec;5(6):476-9.
  172. Selker HP, Oye KA, Eichler HG, Stockbridge NL, Mehta CR, Kaitin KI, McElwee NE, Honig PK, Erban JK, D'Agostino RB. A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials. Clinical Pharmacology and Therapeutics. 2014 Feb;95(2):147-53.
  173. Selker HP. Clinical research and the public: If not them, who? Clin Transl Sci. 2010 Aug;3(4):132-3.
  174. Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D'Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA. 2012 May 9;307(18):1925-33.
  175. Selker HP, Leslie LK, Wasser JS, Plaut AG, Wilson IB, Griffith JL. Tufts CTSI: Comparative effectiveness research as a conceptual framework for a focus on impact. Clin Transl Sci. 2010 Apr;3(2):56-8.
  176. Selker HP, Ruthazer R, Beshansky JR, Sullivan AL, Murman DH, Mader TJ. Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study. Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):86.
  177. Selker HP, Ruthazer R, Terrin N, Griffith JL, Concannon T, Kent DM. Random treatment assignment using mathematical equipoise for comparative effectiveness trials. Clin Transl Sci. 2011 Feb;4(1):10-6.
  178. Selker HP, Strom BL, Ford DE, Meltzer DO, Pauker SG, Pincus HA, Rich EC, Tompkins C, Whitlock EP. White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci. 2010 Feb;3(1):29-37.
  179. Selker HP, Udelson JE, Massaro JM, Ruthazer R, D'Agostino RB, Griffith JL, Sheehan PR, Desvigne-Nickens P, Rosenberg Y, Tian X, Vickery EM, Atkins JM, Aufderheide TP, Sayah AJ, et al. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial). American Journal of Cardiology. 2014 May;113(10):1599-605.
  180. Sheldrick RC, Henson BS, Merchant S, Neger EN, Murphy JM, Perrin EC. The Preschool Pediatric Symptom Checklist (PPSC): development and initial validation of a new social/emotional screening instrument. Academic Pediatrics. 2012 Sep-Oct;12(5):456-67.
  181. Sheldrick RC, Henson BS, Neger EN, Merchant S, Murphy JM, Perrin EC. The baby pediatric symptom checklist: development and initial validation of a new social/emotional screening instrument for very young children. Academic Pediatrics. 2013 Jan-Feb;13(1):72-80.
  182. Sheldrick RC, Neger EN, Perrin EC. Concerns about development, behavior, and learning among parents seeking pediatric care. Journal of Developmental and Behavioral Pediatrics. 2012 Feb;33(2):156-60.
  183. Sheldrick RC, Perrin EC. Evidence-based milestones for surveillance of cognitive, language, and motor development. Academic Pediatrics. 2013 Nov-Dec;13(6):577-86.
  184. Singh R, Visintainer PF, Frantz ID,3rd, Shah BL, Meyer KM, Favila SA, Thomas MS, Kent DM. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol. 2011 Mar;31(3):176-82.
  185. Starmer AJ, Duby JC, Slaw KM, Edwards A, Leslie LK, Members of Vision of Pediatrics 2020 Task Force. Pediatrics in the year 2020 and beyond: Preparing for plausible futures. Pediatrics. 2010 Nov;126(5):971-81.
  186. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest. 2012 Jun;141(6):1441-8. doi: 10.1378/chest.11-2032.
  187. Stefan MS, Belforti RK, Langlois G, Rothberg MB. A simulation-based program to train medical residents to lead and perform advanced cardiovascular life support. Hosp Pract (Minneap). 2011 Oct;39(4):63-9.
  188. Stefan MS, Pekow PS, Nsa W, Priya A, Miller LE, Bratzler DW, Rothberg MB, Goldberg RJ, Baus K, Lindenauer PK. Hospital performance measures and 30-day readmission rates. Journal of General Internal Medicine. 2013 Mar;28(3):377-85.
  189. Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Thorax. 2012 Nov;67(11):977-84.
  190. Stefan MS, Rothberg MB, Shieh MS, Pekow PS, Lindenauer PK. Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest. 2013 Jan;143(1):82-90.
  191. Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Steingrub JS, Lagu T, Lindenauer PK. Epidemiology and outcomes of acute respiratory failure in the United States, 2001 to 2009: a national survey. Journal of Hospital Medicine. 2013 Feb;8(2):76-82.
  192. Su SH, Martel-Laferriere V, Labbe AC, Snydman DR, Kent DM, Laverdiere M, Beliveau C, Logvinenko T, Cohen S, Lachance S, Kiss T, Roy J. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2011 Jul;17(7):1012-7.
  193. Sullivan AL, Beshansky JR, Ruthazer R, Murman DH, Mader TJ, Selker HP. Factors associated with longer time to treatment for patients with suspected acute coronary syndromes: a cohort study. Circulation. Cardiovascular quality and outcomes. 2014 Jan;7(1):86-94.
  194. Susantitaphong P, Alfayez M, Cohen-Bucay A, Balk EM, Jaber BL. Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Resuscitation. 2012 Feb;83(2):159-67.
  195. Susantitaphong P, Altamimi S, Ashkar M, Balk EM, Stel VS, Wright S, Jaber BL. GFR at initiation of dialysis and mortality in CKD: a meta-analysis. Am J Kidney Dis. 2012 Jun;59(6):829-40.
  196. Susantitaphong P, Koulouridis I, Balk EM, Madias NE, Jaber BL. Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis. Am J Kidney Dis. 2012 May;59(5):689-99.
  197. Susantitaphong P, Sewaralthahab K, Balk EM, Eiam-ong S, Madias NE, Jaber BL. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. American Journal of Hypertension. 2013 Mar;26(3):424-41.
  198. Susantitaphong P, Sewaralthahab K, Balk EM, Jaber BL, Madias NE. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review. Am J Nephrol. 2012;35(6):540-7.
  199. Susantitaphong P, Siribamrungwong M, Doi K, Noiri E, Terrin N, Jaber BL. Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis. American Journal of Kidney Diseases. 2013 Mar;61(3):430-9.
  200. Terasawa T, Dahabreh IJ, Nihashi T. Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: A systematic review and meta-analysis. Oncologist. 2010;15(7):750-9.
  201. Thaler DE, Ruthazer R, Di Angelantonio E, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, et al. Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke. 2013 Mar;44(3):675-80.
  202. Thaler DE, Ruthazer R, Weimar C, Mas JL, Serena J, Di Angelantonio E, Papetti F, Homma S, Mattle HP, Nedeltchev K, Mono ML, Jaigobin C, Michel P, Elkind MS, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology. 2014 Jul;83(3):221-6.
  203. Tonyushkina KN, Shen MC, Ortiz-Toro T, Karlstrom RO. Embryonic exposure to excess thyroid hormone causes thyrotrope cell death. J Clin Invest. 2014 Jan 2;124(1):321.
  204. Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW; HALT PKD Study Group. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012 Mar;81(6):577-85.
  205. Torres-Madriz G, Lerner D, Ruthazer R, Rogers WH, Wilson IB. Work-related barriers and facilitators to antiretroviral therapy adherence in persons living with HIV infection. AIDS Behav. 2011 Oct;15(7):1475-82.
  206. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis. Lancet. 2009 Mar 14;373(9667):911-8.
  207. Vaid A, Chweich H, Balk EM, Jaber BL. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J. 2012 Jan-Feb;58(1):51-9.
  208. Volpe GE, Tang AM, Polak JF, Mangili A, Skinner SC, Wanke CA. Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort. Journal of Acquired Immune Deficiency Syndromes. 2013 Sep;64(1):51-7.
  209. Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, Tangri N. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011 Jun;57(6):894-902.
  210. Wagner M, Balk EM, Kent DM, Kasiske BL, Ekberg H. Subgroup analyses in randomized controlled trials: The need for risk stratification in kidney transplantation. Am J Transplant. 2009 Oct;9(10):2217-22.
  211. Weiss CO, Varadhan R, Puhan MA, Vickers A, Bandeen-Roche K, Boyd CM, Kent DM. Multimorbidity and evidence generation. Journal of Internal Medicine. 2014 Apr;29(4):653-60.
  212. Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, et al. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circulation. Cardiovascular Imaging. 2014 Jan;7(1):125-31.
  213. Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM. Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database." Circulation. Cardiovascular Imaging. 2014 May;7(3):573.
  214. Weston A, Golan Y, Holcroft C, Snydman DR. The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function. Clinical Infectious Diseases. 2014 Jun;58(11):1533-9.
  215. Wilson IB, Laws MB, Safren SA, Lee Y, Lu M, Coady W, Skolnik PR, Rogers WH. Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr. 2010 Mar 1;53(3):338-47.
  216. Wooten EC, Hebl VB, Wolf MJ, Greytak SR, Orr NM, Draper I, Calvino JE, Kapur NK, Maron MS, Kullo IJ, Ommen SR, Bos JM, Ackerman MJ, Huggins GS. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circulation. Cardiovascular Genetics. 2013 Feb;6(1):10-8.
  217. Xu K, Rajagopal S, Klebba I, Dong S, Ji Y, Liu J, Kuperwasser C, Garlick JA, Naber SP, Buchsbaum RJ. The role of fibroblast Tiam1 in tumor cell invasion and metastasis. Oncogene. 2010 Dec 16;29(50):6533-42.
  218. Younes A, Oki Y, Bociek RG, Kuruvilla J, Fanale M, Neelapu S, Copeland A, Buglio D, Galal A, Besterman J, Li Z, Drouin M, Patterson T, Ward MR, Paulus JK, Ji Y, Medeiros LJ, Martell RE. Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial. Lancet Oncol. 2011 Dec;12(13):1222-8.
  219. Zhang FF, Kelly MJ, Saltzman E, Must A, Roberts SB, Parsons SK. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014 Mar;133(3):e704-15.
  220. Zhang FF, Rodday AM, Kelly MJ, Must A, MacPherson C, Roberts SB, Saltzman E, Parsons SK. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatric Blood & Cancer. 2014 Jul;61(7):1263-9.
  221. Zucker DR, Deo A, Schmid CH. Dialysis research and N-of-1 trials: Made for each other? Am J Kidney Dis. 2010 Apr;55(4):635-8.
  222. Zuckerman R, Getz K, Kaitin K. A new mechanism for tracking publicly available study volunteer demographics. Drug Inf J. 2011 Jan 1;45(1):55-64.